HemaSphere
(Jun 2022)
P1436: DEVELOPMENT OF A BETA-GLOBIN GENE REPLACEMENT STRATEGY AS A THERAPEUTIC APPROACH FOR ΒETA-THALASSEMIA
- B. Wienert,
- K. Wallace,
- C. Bandoro,
- A. Churi,
- J. Partridge,
- R. Sharma,
- W. Matern,
- S. Treusch,
- D. Dever
Affiliations
- B. Wienert
- 1 Graphite Bio, Inc., South San Francisco, CA, United States of America
- K. Wallace
- 1 Graphite Bio, Inc., South San Francisco, CA, United States of America
- C. Bandoro
- 1 Graphite Bio, Inc., South San Francisco, CA, United States of America
- A. Churi
- 1 Graphite Bio, Inc., South San Francisco, CA, United States of America
- J. Partridge
- 1 Graphite Bio, Inc., South San Francisco, CA, United States of America
- R. Sharma
- 1 Graphite Bio, Inc., South San Francisco, CA, United States of America
- W. Matern
- 1 Graphite Bio, Inc., South San Francisco, CA, United States of America
- S. Treusch
- 1 Graphite Bio, Inc., South San Francisco, CA, United States of America
- D. Dever
- 1 Graphite Bio, Inc., South San Francisco, CA, United States of America
- DOI
-
https://doi.org/10.1097/01.HS9.0000848600.72042.5d
- Journal volume & issue
-
Vol. 6
pp.
1319
– 1320
WeChat QR code